GleamWall
中文EN

AMTX AEMETIS, INC

Industrial Organic Chemicals · Nasdaq · SEC CIK 738214 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY23.6%
TTM net income YoY64.5%
TTM EPS YoY73.5%
Revenue 3-yr CAGR10.8%
Net income 3-yr CAGR—

Margins

Gross margin21.5%
Operating margin7.2%
Net margin-12.5%
FCF margin-14.7%
EBITDA margin11.3%

Returns

ROE—
ROA-11.3%
ROIC (approx.)17.5%
Asset turnover0.90x

Leverage & solvency

Liabilities / assets200.7%
Debt / equity—
Current ratio0.07x
Interest coverage0.32x

Cash quality & payout

Operating cash flow / net income-0.49x
Accruals ratio-16.8%
Payout ratio—
Capex / revenue20.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$88.15M$62.70M$54.62M$43.31M$59.19M$52.24M$42.89M$47.00M
Cost of revenue$58.68M$49.19M$51.86M$45.94M$59.25M$55.60M$47.97M$49.04M
Gross profit$29.47M$13.52M$2.76M$7.72M-$58,000-$3.35M-$5.08M-$2.04M
SG&A expense$8.62M$7.74M$9.09M$10.21M$8.45M$7.32M$10.47M$11.44M
Operating income$20.85M$5.77M-$6.33M-$2.48M-$8.51M-$10.67M-$15.55M-$13.48M
Interest expense$14.55M$13.66M$14.37M$13.94M$12.95M$12.33M$13.69M$12.64M
Pretax income$5.21M-$9.37M-$21.84M-$16.77M-$23.74M-$23.92M-$31.31M-$28.57M
Income tax$2,000$0-$131,000-$11.44M$6,000-$529,000-$6.78M-$12.37M
Net income$5.21M-$9.37M-$21.71M-$5.33M-$23.75M-$23.39M-$24.53M-$16.20M
EBITDA$23.43M$8.32M-$3.80M$111,000-$6.18M-$8.32M-$13.20M-$11.26M
EPS (basic)0.07-0.13-0.33—-0.37-0.41-0.47—
EPS (diluted)-0.02-0.13-0.33—-0.37-0.41-0.47—
Weighted avg. shares (diluted)72.50M70.89M66.80M—63.70M57.68M52.58M—
Balance sheet
Cash & equivalents$3.36M$973,000$4.80M$4.89M$5.58M$1.65M$499,000$898,000
Inventory$12.93M$13.64M$10.38M$11.63M$4.78M$12.37M$22.93M$25.44M
Current assets$29.13M$32.99M$34.69M$26.87M$15.55M$20.09M$28.49M$44.70M
PP&E, net$271.31M$242.83M$222.74M$219.72M$209.97M$204.64M$199.44M$199.39M
Total assets$312.00M$289.18M$270.33M$259.84M$241.12M$240.02M$259.84M$259.30M
Current liabilities$439.82M$415.03M$396.25M$371.26M$343.37M$321.93M$174.60M$143.97M
Short-term debt$376.92M$354.18M$342.63M$317.87M$286.71M$270.61M$119.55M$90.53M
Long-term debt$58.52M$61.72M$62.05M$63.90M$66.79M$73.62M$216.74M$247.53M
Total debt$435.45M$415.89M$404.68M$381.76M$353.50M$344.23M$336.29M$338.06M
Total liabilities$626.20M$611.29M$591.47M$566.67M$545.97M$529.27M$523.21M$523.23M
Shareholders' equity-$314.21M-$322.11M-$321.14M-$306.83M-$304.85M-$289.25M-$280.69M-$263.93M
Net debt$432.09M$414.92M$399.88M$376.87M$347.92M$342.59M$335.79M$337.16M
Shares outstanding73.10M72.05M—66.19M65.00M61.99M54.04M51.14M
Cash flow statement
Operating cash flow$21.95M-$1.88M-$10.56M$5.77M$3.07M-$5.74M$160,000-$12.58M
Capital expenditure$20.22M$8.54M$6.55M$16.56M$4.09M$3.52M$1.82M$6.78M
Free cash flow$1.73M-$10.42M-$17.11M-$10.79M-$1.02M-$9.26M-$1.67M-$19.36M
Investing cash flow-$20.22M-$8.54M-$5.11M-$16.56M-$4.09M-$3.11M-$1.82M-$3.72M
Financing cash flow-$362,000$7.06M$14.70M$10.01M$5.13M$10.02M$1.25M$16.82M
Depreciation & amortization$2.58M$2.54M$2.54M$2.59M$2.33M$2.35M$2.36M$2.22M
Stock-based compensation$1.19M$1.12M$1.70M$795,000$1.39M$1.43M$2.31M$1.39M

Free plan shows the latest 8 periods; Pro shows all 63 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.